Nogapendekin alfa inbakicept with BCG for non-muscle-invasive bladder cancer with carcinoma in situ that is unresponsive to BCG (terminated evaluation)
Technology appraisal
Reference number: TA1163
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.